CRWD's high valuation, customer challenges and competitive headwinds suggest that it is wise to avoid the stock ahead of its first-quarter fiscal 2026 results.

SCHD offers a compelling combination of low fees, high dividend yield, and attractive valuation compared to broader market ETFs like SPY. The ETF is concentrated in value and defensive sectors, making it less diversified but more resilient and income-focused than peers such as VYM and DGRO. Despite lagging in recent total returns, SCHD's lower drawdown and higher yield make it appealing for conservative, income-oriented investors.

Li Auto delivered strong Q1 results, beating earnings and revenue estimates, with impressive delivery growth and industry-leading vehicle margins. I believe Li Auto is the most attractive EV start-up due to its solid profitability, superior margins, and undervalued share price. Despite risks from slowing growth and pricing pressure, Li Auto's low valuation and profitability offer downside protection for long-term investors.

NEW YORK, May 30, 2025 (GLOBE NEWSWIRE) -- Ascendiant Capital Markets LLC (“Ascendiant”) publishes equity research coverage on Society Pass Inc. (Nasdaq: SOPA) (“SoPa” or the “Company”), Southeast Asia's (SEA) next generation, data-driven, loyalty, fintech and e-commerce ecosystem.

HubSpot stock slides after Alphabet drops buyout plan, but rising earnings estimates and AI-driven growth may help HUBS regain traction.

ATI signs a multi-year deal with Airbus for titanium products supply, boosting aerospace and defense leadership.

LI Q1 earnings fall year over year, while revenues rise due to a 15.5% year-over-year increase in vehicle deliveries.

Dell Technologies' first-quarter fiscal 2026 results reflect strong AI-driven growth and an expanding backlog.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your West Pharmaceutical Services, Inc. (NYSE:WST) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/west-pharmaceutical-services-inc-lawsuit-submission-form?prid=151018&wire=1&utm_campaign=18 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Viatris Inc. (NASDAQ:VTRS) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/viatris-inc-lawsuit-submission-form-2?prid=151016&wire=1&utm_campaign=29 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / May 30, 2025 / If you suffered a loss on your Treace Medical Concepts, Inc. (NASDAQ:TMCI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/treace-medical-concepts-inc-lawsuit-submission-form-2?prid=151017&wire=1&utm_campaign=16 or contact Joseph E. Levi, Esq.

Company Launches Far-Reaching Bitcoin Treasury Strategy SARASOTA, Fla., May 30, 2025 (GLOBE NEWSWIRE) -- Trump Media and Technology Group Corp. (Nasdaq, NYSE Texas: DJT) ("Trump Media" or the "Company"), operator of the social media platform Truth Social, the streaming platform Truth+, and the FinTech brand Truth.Fi, announced today that it has closed its previously announced private placement offering (“the Offering”) with approximately 50 institutional investors.

The week has been a bit mixed for gold overall, as we are trying to sort out where to go next. At this point, the market looks likely to grind sideways overall.

The company's earnings didn't dispel concerns it might lose out on designing Amazon's Trainium AI chips. Still, analysts are upbeat.

BOTZ offers broad exposure to robotics and AI. The ETF leans heavily toward industrials and intentional companies, with low semiconductor exposure. It's a refreshing change. However, performance lags peer AI/robotics ETFs.

Regeneron and SNY's itepekimab meets the primary endpoint in one COPD trial but misses in another, leaving future plans under review.

Intellia stock tanks after a patient in its phase III study evaluating gene therapy candidate nex-z in ATTR-CM experiences serious liver enzyme elevation.

Shares of Shoe Carnival (SCVL) advanced Friday after the footwear retailer's profit easily beat estimates, boosted by its Shoe Station stores, which it plans to grow through rebranding.

Shares of U.S. Steel just saw its third downgrade in the past week, but other companies may be in a weaker position.

There is still considerable resistance standing in the way of the technology sector in the United States, as some bearish analysts argue that the current state of trade tariffs hinders their ability to accurately forecast future growth prospects and valuations. However, there is one stock that has managed to position itself among the winners in this space today, regardless of how President Trump works to implement new trade strategies.